FDA Panel Debates COVID Vaccine Recipe
Digest more
Top News
Overview
Impacts
The itching, known medically as pruritus, was so bad that affected people described "significant and persistent impact on quality of life and ability to function."
The Trump administration is proposing a $6.8 billion budget request for the U.S. Food and Drug Administration for the 2026 fiscal year, its Commissioner Martin Makary said on Thursday, a cut of around 5.
The U.S. Food and Drug Administration has issued a warning about a rare but severe reaction that can happen to people who stop taking oral allergy medicines like Zyrtec or Xyzal.
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of other FDA issues currently in the political spotlight. The FDA’s budget was not mentioned in the president’s preliminary spending package,
6hon MSN
The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being forthcoming about its research.
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic lung disease commonly known as "smoker's lung", the company said on Thursday.
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
The Food and Drug Administration (FDA) announced Wednesday plans to help states and Indian tribes import cheaper prescription drugs from Canada. The initiative is in support of President Donald Trump’s executive order on May 12 which promised to deliver “most-favored nation prescription drug pricing” to America,
Although the side effect is rare, the FDA said some patients experienced severe itching that required medical attention.
(CNN) – The crackdown on off-brand weight loss and diabetes treatment drugs is about to take effect, meaning supplies for the treatments are likely to tighten. A federal deadline to halt sales of the GLP-1 medications arrives this week.